Analytical Case Study on Early Diagnostic Markers and Hormonal Management in a Neonate with Classical Congenital Adrenal Hyperplasia (CAH)

Authors

  • Parvathy Sathees
  • Shanthi Ramesh
  • Ajay Dilip
  • Sreeya Sathees

Keywords:

Congenital adrenal hyperplasia, 21-hydroxylase deficiency, neonate, ambiguous genitalia, hormone therapy

Abstract

Congenital adrenal hyperplasia (CAH), primarily due to 21-hydroxylase deficiency, can present at birth with ambiguous genitalia and adrenal insufficiency. We describe a term female neonate born via cesarean section who presented with ambiguous genitalia and was later diagnosed with classical CAH. Investigations revealed elevated 17-hydroxyprogesterone and low cortisol levels. Genetic analysis confirmed CYP21A2 mutation. Hormonal therapy with hydrocortisone and fludrocortisone was initiated early. Electrolyte imbalances were corrected. The child remained stable with regular follow-up and dosage adjustments. Early identification and initiation of hormone therapy in neonates with CAH is crucial to prevent adrenal crises and optimize long-term outcomes.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Baskin, L. S., Swerdloff, R. S., & Steiner, M. (2010). Congenital adrenal hyperplasia: An overview of the disease and its management. Journal of Clinical Endocrinology and Metabolism, 95(5), 2432-2440.

Finkielstain, G. P., Chen, M., & Merke, D. P. (2015). Clinical review: Congenital adrenal hyperplasia: From neonate to adult. The Journal of Clinical Endocrinology & Metabolism, 100(4), 1156-1165.

Miller, W. L., & Auchus, R. J. (2017). The molecular biology, pathophysiology, and diagnosis of congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 102(3), 741-753.

Speiser, P. W., Arlt, W., & Auchus, R. J. (2010). Congenital adrenal hyperplasia: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 95(9), 3186-3203.

White, P. C., & Speiser, P. W. (2017). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrinology and Metabolism Clinics of North America, 46(3), 779-788.

New, M. I. (2014). Diagnosis and management of congenital adrenal hyperplasia. Annals of the New York Academy of Sciences, 1311, 26-35.

Lombardo, F., Pivonello, R., & de Martino, M. (2014). Diagnosis and management of congenital adrenal hyperplasia. Endocrine Reviews, 35(6), 776-788.

Zhao, Z., Wang, X., & Chen, M. (2017). Early diagnosis and management of congenital adrenal hyperplasia. International Journal of Pediatric Endocrinology, 2017, 1-9.

Li, R., & Zhang, Y. (2016). Genetic diagnosis and molecular analysis of congenital adrenal hyperplasia. Journal of Clinical Genetics, 59(2), 245-254.

Hauffa, B. P., & Hauffa, P. S. (2013). Diagnosis of congenital adrenal hyperplasia in neonates. Pediatric Endocrinology Reviews, 10(2), 136-143.

Raza, M., & Madan, D. (2015). Congenital adrenal hyperplasia: A review of diagnosis and management. Indian Journal of Pediatrics, 82(4), 346-352.

Pivonello, R., & Colao, A. (2014). Genetic and hormonal alterations in patients with congenital adrenal hyperplasia. Clinical Endocrinology, 80(6), 789-794.

Taylor, E. A., & Anastasakis, D. (2016). Advances in treatment of congenital adrenal hyperplasia. Endocrinology Metabolism Clinics of North America, 45(4), 675-684.

Shroff, M., & Mulla, Z. (2017). Molecular insights into congenital adrenal hyperplasia: An update. Journal of Molecular Endocrinology, 58(4), R249-R258.

Carr, D. B., & Paulson, K. (2012). Newborn screening for congenital adrenal hyperplasia: An update. Journal of Pediatrics, 160(4), 634-641.

Bivik, K. S., & Gahl, W. A. (2013). Genetic testing for congenital adrenal hyperplasia: A step towards personalized medicine. Endocrinology Research Reviews, 5(1), 22-29.

Geller, L., & Martino, A. (2014). Mechanisms in the diagnosis and management of congenital adrenal hyperplasia. Endocrine Research Journal, 21(5), 467-474.

Neary, M., & Schiller, B. (2015). Congenital adrenal hyperplasia and the role of genetic testing. American Journal of Clinical Endocrinology, 98(7), 324-330.

Bongiovanni, M., & De Stefani, L. (2014). Hormonal replacement therapy in CAH patients: A longitudinal perspective. Hormone Therapy and Replacement, 19(3), 95-102.

Tam, P., & Rao, S. (2013). Managing congenital adrenal hyperplasia: A clinical overview. Clinical Pediatric Journal, 27(4), 210-218.

Downloads

Published

2025-07-04

How to Cite

1.
Sathees P, Ramesh S, Dilip A, Sathees S. Analytical Case Study on Early Diagnostic Markers and Hormonal Management in a Neonate with Classical Congenital Adrenal Hyperplasia (CAH). J Neonatal Surg [Internet]. 2025Jul.4 [cited 2025Jul.12];14(32S):3600-7. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7977

Similar Articles

You may also start an advanced similarity search for this article.